A bill to amend the Controlled Substances Act to require identification by manufacturer of each schedule II dosage unit produced.
Dangerous Drug Identification Act - Makes it unlawful to manufacture or distribute solid oral form controlled substances in schedule II of the Controlled Substances Act unless each solid oral form dosage unit carries a manufacturer's identification as required by regulation of the Attorney General. (Adds 21 U.S. 825(e))
Referred to House Committee on Interstate and Foreign Commerce.
Introduced in Senate
Referred to Senate Committee on Judiciary.
checking server…
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line